Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04418219
Title A Breast Cancer Vaccine (SV-BR-1-GM) in Combination With Pembrolizumab for the Treatment of Persistent, Recurrent, or Metastatic Breast Cancer
Recruitment Withdrawn
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Thomas Jefferson University
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.